A systematic review of the soteria paradigm for the treatment of people diagnosed with schizophrenia

Schizophrenia Bulletin

Volumn 34, Issue 1, 2008, Pages 181-192

  Calton, Tim ^a   Ferriter, Michael ^b   Huband, Nick ^b   Spandler, Helen ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Evidence based mental health; Mental health services; Psychological treatments; Schizophrenia; Soteria

Indexed keywords

CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMPIRICISM; FOLLOW UP; HEALTH CARE; HUMAN; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ALGORITHMS; HOSPITALIZATION; HUMANS; PATIENT ADMISSION; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 37149055954     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm047     Document Type: Review

References (136)

1. Burston D. The Crucible of Experience: R.D. Laing and the Crisis of Psychotherapy. Boston, Mass: Harvard University Press; 2000.
2. Cooper D. Psychiatry and Anti-psychiatry. London, UK: Tavistock Press; 1967.
3. Jenner FA, Monteiro ACD, Zagalo-Cardoso JA, Cunha-Oliveira JA. Schizophrenia: A Disease or Some Ways of Being Human? Sheffield, UK: Sheffield University Press; 1993.
4. Pullen G. Schizophrenia: hospital communities for the severely disturbed. In: Campling P, Haigh R, eds. Therapeutic Communities: Past, Present and Future. London, UK: Jessica Kingsley; 1999:140-150.
5. Barnes M, Berke J. Mary Barnes: Two Accounts of a Journey Through Madness. London, UK: MacGibbon and Kee; 1971.
6. Mosher LR, Hendrix V. Soteria: Through Madness to Deliverance. San Francisco, Calif: XLibris; 2004.
7. Mosher LR. Soteria-California and its successors: therapeutic ingredients, Wie wirkt Soteria? In: Ciompi L, Hoffmann H, Broccard M, eds. - Ein atypische Psychosenbehandlung kritisch durchleuchtet [How does Soteria work? - an unusual treatment of schizophrenia, critically evaluated]. New York, NY: Huber; 2001:13-43.
8. Mosher LR, Bola JR. Soteria California and its American successors: therapeutic ingredients. Ethical Hum Psychiatry Psychol. 2004;6:147-163.
9. Soteria Network, UK.Inaugural Conference 'Alternatives - What Alternatives? Birmingham, UK: Centre for Community Mental Health, University of Centre for Community Mental Health, University of Central England; 2005.
10. Ciompi L, Dauwalder HP, Maier C, et al. The pilot project "Soteria Bern": clinical experiences and results. Br J Psychiatry. 1992;161:145-153.
11. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons Ltd; 2006.
12. World Health Organization. International Classification of Mental and Behavioural Disorders: ICD-10. Geneva, Ill: WHO; 1992.
13. Mosher LR, Menn AZ, Matthew SM. Soteria: evaluation of a home-based treatment for schizophrenia. Am J Orthopsychiatry. 1975;45:455-467.
14. Mosher LR. Implications of family studies for the treatment of schizophrenia. Ir Med J. 1976;69:456-463.
15. Mosher LR, Menn AZ. Soteria: an alternative to hospitalisation for schizophrenia. Curr Psychiatr Ther. 1975;15:287-296.
16. Mosher LR, Menn AZ. Soteria House: one year outcome data. Psychopharmacol Bull. 1977;13:46-48.
17. Mosher LR, Menn AZ. Community residential treatment for schizophrenia: two-year follow-up. Hosp Community Psychiatry. 1978;29:715-723.
18. Mosher LR, Menn AZ. Soteria: an alternative to hospitalisation for schizophrenics. Curr Psychiatr Ther. 1982;21:189-203.
19. Matthews SM, Roper MT, Mosher LR, Menn AZ. A non-neuroleptic treatment for schizophrenia: analysis of the two-year post-discharge risk of relapse. Schizophr Bull. 1979;5:322-333.
20. Mosher LR. Soteria: a therapeutic community for psychotic persons. Int J Ther Communities. 1991;12:53-67.
21. Mosher LR, Vallone R, Menn AZ. The treatment of acute psychosis without neuroleptics: six-week psychopathology outcome data from the Soteria project. Int J Soc Psychiatry. 1995;41:157-173.
22. Mosher LR. Soteria and other alternatives to acute psychiatric hospitalisation. J Nerv Ment Dis. 1999;187:142-149.
23. Bola JR. Evaluation of treatment in early acute episode psychosis: a secondary analysis of the Soteria study. Dissertation Abstract International Section A. Humanities and Social Sciences. Ann Arbor, MI: Proquest Information and Learning; 1999;60(3):8-86.
24. Bola JR, Mosher LR. Predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophr Bull. 2002;28:559-575.
25. Bola JR, Mosher LR. Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project. J Nerv Ment Dis. 2003;191:219-229.
26. Ciompi L. The Soteria-concept, theoretical bases and practical 13 year experience with a milieu-therapeutic approach to acute schizophrenia. Seishin Shinkeigaku Zasshi. 1997;99:634-650.
27. Ciompi L, Bernasconi R. Soteria Bern, Erste Erfahrungen mit einer neuartigen Milieutherapie fur akute Schizophrenie. [Soteria Bern. Initial experiences with a new milieu therapy for acutely schizophrenic patients]. Psychiatr Prax. 1986;13:172-176.
28. Ciompi L, Dauwalder HP, Maier C, Aebi E. Das Pilotprojekt Soteria Bern zur Behandlung akut Schizophrener. I Konzeptuelle Grundlagen, praktische Realisierung, klinische Erfahrungen [The pilot project Bern in treatment of acute schizophrenic patients. I Conceptual principles, practical realisation, clinical experiences]. Nervenarzt. 1991;62:428-435.
29. Ciompi L, Kupper Z, Aebi E, et al. Das Pilotprojekt Soteria Bern zur Behandlung akut Schizophrener. II. Ergebnisse einer vergleichenden prospektiven Verlaufsstudie uber 2 jahre. [The pilot project Soteria Bern in treatment of acute schizophrenic patients. II. Results of a comparative prospective follow-up study over 2 years]. Nervenarzt. 1993;64:440-450.
30. Mosher LR, Vallone R, Menn A. Identical twins discordant for schizophrenia: Neurologic findings. Arch Gen Psychiatry. 1971;29:715-723.
31. Sokis DA. A breif follow-up rating. Compr Psychiatry. 1970;11:445-459.
32. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ. 1998;317:1181-1184.
33. Ferriter M, Huband N. Does the non-randomised controlled study have a place in the systematic review? A pilot study. Crim Behav Ment Health. 2005;15:111-120.
34. Ahern L, Fisher D. An alternative to PACT; recovery at your own PACE. Ment Health Spec Interest Q. 2001;24:3-4.
35. Ahern L, Fisher D. Recovery at your own PACE (personal assistance in community existence). J Psychosoc Nurs Ment Health Serv. 2001;39:22-33.
36. Bola JR, Mosher LR. Clashing ideologies or scientific discourse? Schizophr Bull. 2002;28:583-588.
37. Bola JR, Mosher LR, Cohen D. Treatment of newly diagnosed psychosis without antipsychotic drugs: the Soteria project. Foundations of social work knowledge. In: Kirk SA, ed. Mental Disorders in the Social Environment: Critical Perspectives. New York, NY: Columbia University Press; 2005:368-384.
38. Carpenter WT, Buchanan RW. Commentary on the Soteria project: misguided therapeutics. Schizophr Bull. 2002;28:577-581.
39. Chamberlin J. Loren Mosher; an appreciation. Psychiatr Rehabil J. 2004;28:103-104.
40. Ciompi L. Soteria: konnen die wirksamen faktoren auch im klinikalltag realisiert werden? [Soteria: can efficient factors also be realised in conventional hospital treatment?] Nervenheilkunde. 2001;20:78-84.
41. Ciompi L. Fur eine sanftere Psychiatrie Zum Menschen und Krankheitsverstandnis der Affektlogik [To a more gentle psychiatry. Towards persons and affect logic's understanding of illness]. Psychiatr Prax. 2003;30(supp1):28-36.
42. Dauwalder JP, ed. Soteria Bern, treatment and prevention of schizophrenia without neuroleptic drugs. Lisse, Netherlands: Swets and Zeitlinger; 1990.
43. De Crescente M, Mosher L. (1934-2004). J Eur Psychoanal. 2004;18:145-146.
44. Delaney KR. Milieu therapy: a therapeutic loophole. Perspect Psychiatr Care. 1997;33:19-28.
45. Fabre JP. Soteria house: une approche different du traitment de la schizophrenie. [Soteria house: a different approach to treatment of schizophrenia]. Inf Psychiatr. 1979;55:917-920.
46. Gosden R. Duty of care to students in extreme mental states. Ethical Hum Sci Serv. 2001;3:33-45.
47. Greenblatt M, Budson RD. A symposium: follow-up studies of community care. Am J Psychiatry. 1976;133:916-921.
48. Guazzeli M, Palagini L, Giuntoli L, et al. Outcomes of patients with schizophrenia in a family-style, residential, community-based program in Italy. Psychiatr Serv. 2000;51:1113-1115.
49. Harangozo J. Solidaritas a soteriaval es masokkal: merre halad a magyar pszichiatria? [Solidarity with Soteria and others]. Psychiatr Hung. 2000;15:221-223.
50. Hirschfeld RM, Matthews SM, Mosher LR, Menn AZ. Being with madness: personality characteristics of three treatment staffs. Hosp Community Psychiatry. 1977;28:267-273.
51. Johnson DL. Understanding and treating schizophrenia: contemporary research, theory, and practice. Psychiatr Rehabil J. 2005;28:411-412.
52. Mazzola GS. Le soterie. Acta Neurol (Napoli). 1970;25:723-730.
53. Mosher LR, Reifman A, Menn AZ. Characteristics of non-professionals serving as primary therapists for acute schizophrenics. Hosp Community Psychiatry. 1973;24:391-396.
54. Menn AZ, Mosher LR. The Soteria project - an alternative to hospitalisation for schizophrenics: some clinical aspects. In: Jorstad J, Ugelstad E, eds. Schizophrenia. Oslo, Norway: Universitetsforlaget; 1976:347-372.
55. Mosher LR, Menn AZ. Lowered barriers in the community: the Soteria model. In: Stein LI, Test MA, eds. Alternatives to Mental Hospital Treatment. New York, NY: Plenum Press; 1977:75-113.
56. Mosher LR, Menn AZ. Enhancing psychosocial competence in schizophrenia: preliminary results of the Soteria project. In: Fann WE, Karacan IC, Pokomy AD, Williams RL, eds. Phenomenology and Treatment of Schizophrenia. New York, NY: Spectrum; 1978:371-386.
57. Mosher LR, Menn AZ. Shershow JC. Schizophrenia: Science and Practice. Cambridge, Mass: Harvard University Press; 1978:223-239.
58. Mosher LR, Menn AZ. Soteria: an alternative to hospitalisation for schizophrenics. In: Lamb HR, ed. New Directions for Mental Health Services: Alternatives to Acute Hospitalisation. San Francisco, Calif: Jossey-Bass; 1979:189-206.
59. Mosher LR, Menn AZ. Scientific evidence and system change: the Soteria experience. In: Stierlin H, Wynne LC, Wirsching M, eds. Psychosocial Interventions in Schizophrenia. Heidelberg, Germany: Springer-Verlag; Vol 21 (1983):93-108.
60. Mosher LR. Alternatives to psychiatric hospitalisation: why has research failed to be translated into practice? N Engl J Med. 1983;309:1479-1480.
61. Mosher LR, Menn AZ. An alternative to hospitalisation for schizophrenia. In: Masserman JH, ed. Current Psychiatric Therapies. New York, NY: Grune and Stratton; Vol 21 (1984)189-206.
62. Mosher LR. Community residential treatment: alternatives to hospitalisation. In: Bellack AS, ed. A Clinical Guide for the Treatment of Schizophrenia. New York, NY: Plenum Press; 1989:135-161.
63. Mosher LR, Hendrix V. In Memoriam: R.D. Laing. An anti-psychiatrist's contribution to contemporary psychiatry. Int J Ther Communities. 1991;12:43-51.
64. Mosher LR, Vallone R, Menn AZ, Hendrix V, Fort DC. Treatment at Soteria House: A Manual for the Practice of Interpersonal Phenomenology. Washington, DC: National Institute of Mental Health; 1992.
65. Mosher LR, Burti L. Alternatives to hospitalisation. In: Mosher LR, Burti L, eds. Community Mental Health: A Practical Guide. New York, NY: WW Norton; 1994:119-142.
66. Mosher LR. The Soteria project: the first generation American alternatives to psychiatric hospitalisation. In: Warner R, ed. Alternatives to the Hospital for Acute Psychiatric Treatment. Washington, DC: American Psychiatric Association; 1995:112-125.
67. Mosher LR. The Soteria Project: therapeutic communities for psychotic persons. In: Breggin P, Stem M, eds. The Psychotic Patient. Binghampton, NY: Haworth; 1996:43-58.
68. Mosher LR, Bola JR. Das Soteria project: einschtazung des affekts un interventionsformen [The Soteria project: ?assessment of affect and interventions]. In: Machleidt W, Halternet H, Gaslipp P, eds. Schizophrenie - eine affektive Erkrankung?. Stuttgart, Germany: Schattauer; 1999:243-257.
69. Mosher LR, Bola JR. The Soteria project: twenty-five years of swimming upriver. Complexity and Change. 2000;9:68-74.
70. Mosher LR. Die Anwendung von therapeutischen prinzipien der soteria in der gemeindepsychiatrischen versorgung ?[Application of Soteria principles to community psychiatric care). In: Wollschlager M, ed. Socialpsychiatrie: Entwicklungen-Kontroversen-Perspektiven. Tubingen, Germany: Verlag; 2001:497-503.
71. Mosher LR. Treating madness without hospitals: Soteria and its successors. In: Schneider KJ, Bugental JFT, Broccard M, eds. The Handbook of Humanistic Psychology. Thousand Oaks, Calif: Sage; 2001:389-401.
72. Mosher LR. Non-hospital, non-drug interventions with first episode psychosis. In: Read J, Mosher LR, Bentall R, eds. Models of Madness: Psychological, Social, and Biological Approaches to Schizophrenia. Hove, UK: Brunner-Routledge; 2004:349-364.
73. Peltzer K, Machleidt W. A traditional (African) approach towards the therapy of schizophrenia and its comparison with Western models. Therapeutic communities. Int J Ther Support Organ. 1992;13:229-242.
74. Scharfetter CH. Psychotherapie fur schizophrenie: historischer uberblick und grundsatze. (Historical development and principles of psychosocial therapeuric interventions for schizophrenics). Schweiz Arch Neurol Psychiatr. 1999;150:217-224.
75. Schneider KJ, Bugental JFT, Pierson JF. The Handbook of Humanistic Psychology: Leading Edges in Theory, Research, and Practice. Thousand Oaks, Calif: Sage Publications Inc; 2001.
76. Sharfstein SS. Soteria and the medical marketplace. J Nerv Ment Dis. 1999;187:129-130.
77. Smith J. The healing elements of an environment for those with chronic psychosis. Therapeutic communities. Int J Ther Support Organ. 2000;21:37-46.
78. Thomas P. Soteria: salvation for the twenty-first century. Asylum. 2004;14:7.
79. Wendt RJ, Mosher LR, Matthews SM, Menn AZ. A comparison of two treatment environments for schizophrenia. In: Gunderson JG, Will OA, Mosher LR, eds. The Principles and Practice of Milieu Therapy. New York, NY: Jason Aronson; 1983:17-33.
80. Wilson HS. Presencing: social control of "schizophrenics" in an antipsychiatric community. In: Kneisl CR, Wilson HS, eds. Current Perspectives in Psychiatric Nursing. St Louis, Mo: C.V.Mosby; Vol 1 (1976)164-175.
81. Wilson HS. Conjoint becoming: study of Soteria. In: Kneisl CR, Skodol HS, eds. Current Perspectives in Psychiatric Nursing. St Louis, Mo: C.V.Mosby; Vol 2 (1978)135-148.
82. Wilson HS. Deinstitutionalised Residential Care for the Mentally Disordered: The Soteria House Approach. New York, NY: Grune and Stratton; 1982.
83. Wilson HS. Presencing: social control of schizophrenics in an antipsychiatry community: an illustration of grounded theory. In: Munhall PL, Oiler CJ, eds. Nursing Research: a Qualitative Perspective. Norwalk, CT: Appleton-Century-Croft; 1986:131-144.
84. Wilson HS. Replicating a low EE environment: the Soteria approach ten years later. Fla Nurs Rev. 1990;13:1-8.
85. Windgasssen K, Tolle R. Wie Konnen wir die Schizophrenen besser behandeln? Anmerkungen zu der Arbeit von L.Ciompi, H.P. Dauwalder, C.H. Maier und E. Aebi. Das Pilotprojekt Soteria Bern zur Behandlung akut Schizophrener. [How can we improve treatment of schizophrenia? Comments on the contribution by L. Ciompi, H.P.Dauwalder, C.H. Maier and E. Aebi. The Soteria Bern pilot projects of treatment of acute schizophrenic patients]. Nervenarzt. 1992;63:577-579.
86. Zapotoczky HG, Wenzel T. The Scientific Dialogue: From Basic Research to Clinical Practice. Lisse, Netherlands: Swets and Zeitlinger Publishers; 1990.
87. Ciompi L, Hoffmann H, Broccard M, eds. Wie wirkt Soteria? Eine atypische Schizophreniebehandlung - kritisch durchleuchtet. (How does Soteria work? An unusual treatment of schizophrenia, critically evaluated). Bern: Huber; 2001.
88. Ciompi L, Hoffmann H. Soteria Berne: an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic. World Psychiatry. 2004;3:140-146.
89. Bola JR. Medication-free research in early episode schizophrenia: evidence of long-term harm? Schizophr Bull. 2006;32:288-296.
90. Ciompi L, Hoffmann H, Leisinger S. 'Soteria-Station'? - Zur Frage des Namens von psychiatrischen Krankenhausstationen mit sog Soteria-Elementen ['Soteria ward'? - on the name of hospital wards with so-called Soteria elements]. Krankenhauspsychiatrie. 2005;16:120-124.
91. American Psychiatric Association.DSM-II: Diagnostic and Statistical Manual of Mental Disorders. 2nd ed. Washington, DC: APA; 1980.
92. Jablensky A, Sartorius N, Emberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organisation ten-country study. Psychol Med Monogr Suppl. 1992;22:1-97.
93. World Health Organization. Schizophrenia: An International Follow-up Study. New York, NY: John Wiley & Sons; 1992.
94. Davis JM. Recent developments in the drug treatment of schizophrenia. Am J Psychiatry. 1976;133:208-214.
95. Hogarty GE, Goldberg SC, Schooler S, Ulrich RF. Collaborative study group.Drugs and sociotherapy in the aftercare of schizophrenic patients II. Two year relapse rates. Arch Gen Psychiatry. 1974;31:603-608.
96. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first episode schizophrenia. Am J Psychiatry. 1992;149:1183-1188.
97. Warner D. Problems with early and very early interventions in psychosis. Br J Psychiatry. 2005;187:104-107.
98. Bentall RP, Morrison AP. More harm than good: the case against using antipsychotic drugs to prevent sever mental illness. J Ment Health. 2002;11:351-356.
99. Moncrieff J. Clozapine vs conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. Br J Psychiatry. 2003;183:161-166.
100. Oehl M, Hummer M, Fleischhacker WW. Compliance with antipsychotic treatment. Acta Psychiatr Scand. 2000;102:83-86.
101. Geddes J, Freemantle N, Harrison P, Bebbington P. A typical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321:1371-1376.
102. Jones PB, Barnes TE, Davies L, Dunn G, et al. Randomised controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia. Arch Gen Psychiatry. 2006;63:1079-1087.
103. Lieberman JA, Scott Stroup T, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med. 2005;353:1209-1224.
104. Hennessy S, Bilker WB, Knauss JS. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2002;325:1070-1072.
105. Zarate CA, Patel J. Sudden cardiac death and antipsychotic drugs: do we know enough? Arch Gen Psychiatry. 2001;58:1168-1171.
106. Rogers A, Day JC, Williams B, et al. The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Soc Sci Med. 1998;47:1313-1323.
107. Day J, Kinderman P, Bentall R. Discordant views of neuroleptic side-effects: a potential source of conflict between patients and professionals. Acta Psychiatr Scand. 1997;97:93-97.
108. Lewis S, Tarrier N, Drake RJ. Integrating non-drug treatments in early schizophrenia. Br J Psychiatry. 2005;187:65-71.
109. Podvoll EM. Recovering Sanity: A Compassionate Approach to Understanding and Treating Psychosis. Boston, Mass: Shambhala; 2003.
110. Read J, Mosher L, Bentall R. Models of Madness: Psychological, Social and Biological Approaches to Schizophrenia. Hove, UK: Brunner-Routledge; 2004.
111. Amering M, Stasny P, Hopper K. Psychiatric advanced directives: a qualitative study of informed deliberations by mental health service users. Br J Psychiatry. 2005;186:247-252.
112. Atkinson JM, Garner HC, Patrick H, Stewart S. Issues in the development of advanced directives in mental health care. J Ment Health. 2003;12:463-474.
113. National Institute for Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London, UK: NICE; 2002.
114. Department of Health. Building on the Best: Choice, Responsiveness and Equity in the NHS. London, UK: DoH; 2003.
115. Department of Health. National Service Framework for Mental Health. London, UK: DoH; 1999.
116. Fulford KWM. Concepts of disease and the meaning of patient-centred care. In: Fulford KWM, Hope T, eds. Essential Practice in Patient-Centred Care. Oxford, UK: Blackwell Science Ltd; 1996:3-4.
117. Hope T. Evidence-based patient choice and psychiatry. Evid Based Ment Health. 2002;5:100-101.
118. Kravitz RL, Duan NH, Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 2004;82:661-687.
119. General Medical Council. Seeking Patients' Consent: The Ethical Considerations. London, UK. GMC; 1998.
120. Grisso T, Appelbaum PS. Comparison of standards for assessing patients' capacities to make treatment decisions. Am J Psychiatry. 1995;152:1033-1037.
121. Cairns R, Maddock C, Buchanan A, et al. Prevalence and predictors of mental incapacity in psychiatric in-patients. Br J Psychiatry. 2005;187:379-385.
122. Jeste DV, Saks E. Decisional capacity in mental illness and substance use disorders: empirical database and policy implications. Behav Sci Law. 2006;24:607-628.
123. Harding CC, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with severe mental illness. II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry. 1987;144:727-737.
124. Vaughn C, Leff J. The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. Br J Psychiatry. 1976;129:125-137.
125. Alanen YO, Lehtinen K, Rakkolainen V, Aaltonen J. Need-adapted treatment of new schizophrenic patients: experiences and results of the Turku Project. Acta Psychiatr Scand. 1991;83:363-372.
126. Carpenter WT, McGlashan TH, Strauss JS. The treatment of acute schizophrenia without drugs: an investigation of some current assumptions. Am J Psychiatry. 1977;134:14-20.
127. Cullberg J, Levander S, Holmqvist R, Mattsson M, Wieselgren IM. One-year outcome in first episode psychosis patients in the Swedish parachute project. Acta Psychiatr Scand. 2002;106:276-285.
128. Lehtinen V, Aaltonen J, Koffert T, Rakkolainen V, Syvalahti E. Two year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? Eur Psychiatry. 2000;15:312-320.
129. Carpenter WT, Schooler NR, Kane JM. The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry. 1997;54:401-407.
130. Carpenter WT. The risk of medication-free research. Schizophr Bull. 1997;23:11-18.
131. Carpenter WT. Medication-free research and patient safety. Schizophr Bull. 1998;24:35-36.
132. Fins JJ, Miller FG. The call of the Sirens: navigating the ethics of medication-free research in schizophrenia. Arch Gen Psychiatry. 1997;54:415-416.
133. Moser DJ, Reese RL, Schultz SK, et al. Informed consent in medication-free schizophrenia research. Am J Psychiatry. 2005;162:1209-1211.
134. Shumway M. Preference weights for cost-outcome analyses of schizophrenia treatments: comparison of four stakeholder groups. Schizophr Bull. 2003;29:257-266.
135. Shumway M, Sauders T, Shern D, et al. Preferences for schizophrenia treatment outcomes among public policy makers, consumers, families, and providers. Psychiatr Serv. 2003;54:1124-1128.
136. Agar-Jacomb KM. Mental Health Crisis Services: What do Service Users Need When in Crisis? A Retrospective Study. Auckland, New Zealand: Department of Psychology, University of Auckland; 2006.